This model has direct implications for cancer therapy as it suggests that to guide therapy,patients should be screened for PI3K/AKT pathway activation or for multiple mutations along thepathway rather than for a single gene mutation (Janku et al, 2012; Rodon et al, 2013). This evidence concerns the gene PIK3CA and cancer.